Peer-reviewedCC BYDiagnostics (Basel, Switzerland)
Serum Tumstatin and Vascular Endothelial Growth Factor Levels in Patients with Rosacea: A Cross-Sectional Case–Control Study
- 1Department of Dermatology and Venereology, Faculty of Medicine, , 23119 Elazığ, Türkiye
- 2Department of Medical Biochemistry, Faculty of Medicine, , 23119 Elazığ, Türkiye
Related
- Serum Vascular Endothelial Growth Factor and C-reactive Protein Serve As Biomarkers of Joint Health in Severe Haemophilia A: A Cross-Sectional Study From India.
- Serum Osteopontin Is Associated with Cardio-Ankle Vascular Index-Defined Arterial Stiffness in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study
- Vascular endothelial growth factor mRNA in eutopic and ectopic endometrium
- Intravitreal Anti-vascular Endothelial Growth Factor Injection Practices Among Indonesian Vitreoretinal Specialists: Findings From a 2021 National Survey
- Educational attainment and disease severity are associated with willingness to pay for rosacea treatment in Southwest China: a cross-sectional study
BibTeX
@article{dıgıs2026serum,
title = {{Serum Tumstatin and Vascular Endothelial Growth Factor Levels in Patients with Rosacea: A Cross-Sectional Case–Control Study}},
author = {Mahir Dığış and Emel Güneş and Kısmet Kaya and Betül Demir and Süleyman Aydın},
journal = {Diagnostics (Basel, Switzerland)},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13703348},
note = {CC BY},
}
RIS
TY - JOUR
TI - Serum Tumstatin and Vascular Endothelial Growth Factor Levels in Patients with Rosacea: A Cross-Sectional Case–Control Study
AU - Mahir Dığış
AU - Emel Güneş
AU - Kısmet Kaya
AU - Betül Demir
AU - Süleyman Aydın
PY - 2026
DA - 2026/10/01
JO - Diagnostics (Basel, Switzerland)
UR - https://europepmc.org/article/PMC/PMC13703348
SN - 2075-4418
ER -